|
ZNF747 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.060200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.586700E-04 |
| Normal-vs-Stage2 |
4.630400E-01 |
| Normal-vs-Stage3 |
5.078600E-01 |
| Normal-vs-Stage4 |
1.127190E-01 |
| Stage1-vs-Stage2 |
1.262370E-03 |
| Stage1-vs-Stage3 |
6.38899999999554E-05 |
| Stage1-vs-Stage4 |
2.76690000000634E-06 |
| Stage2-vs-Stage3 |
7.888400E-01 |
| Stage2-vs-Stage4 |
6.801200E-01 |
| Stage3-vs-Stage4 |
3.814000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.638200E-01 |
| Normal-vs-AfricanAmerican |
2.757400E-01 |
| Normal-vs-Asian |
4.445800E-02 |
| Caucasian-vs-AfricanAmerican |
7.087200E-01 |
| Caucasian-vs-Asian |
2.338600E-01 |
| AfricanAmerican-vs-Asian |
2.704400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.920000E-01 |
| Normal-vs-Female |
3.020500E-03 |
| Male-vs-Female |
3.402900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.941200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.949700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.051800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.839400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.800000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.761400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.138600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.039600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.357200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.574800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.48639999999023E-05 |
| Normal-vs-Grade 2 |
3.097600E-03 |
| Normal-vs-Grade 3 |
7.071600E-01 |
| Normal-vs-Grade 4 |
6.880800E-03 |
| Grade 1-vs-Grade 2 |
3.524400E-02 |
| Grade 1-vs-Grade 3 |
1.624360E-03 |
| Grade 1-vs-Grade 4 |
4.43350000001175E-06 |
| Grade 2-vs-Grade 3 |
4.301500E-03 |
| Grade 2-vs-Grade 4 |
1.66229999987166E-07 |
| Grade 3-vs-Grade 4 |
1.780470E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.77720000005266E-06 |
| Normal-vs-ccB subtype |
4.755600E-02 |
| ccA subtype-vs-ccB subtype |
1.94100291395216E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.271800E-01 |
| Normal-vs-N1 |
2.005400E-01 |
| N0-vs-N1 |
1.832820E-01 |
|
|
